Vascular Access Related Infections in Hemodialysis Children and the Impact of Implementation of CDC Guidelines and Tools on the Control of these Infections: A Single Centre Experience from Egypt

Sawsan S.  El Moselhy; Mohamed Nasr  El-Sharawi; Marwa Waheed  Abd Elhady; Mohamed Awad  Ibrahim Qasim; Ragia Marei  Said

doi:10.6000/1929-4247.2024.13.03.7

Authors

Sawsan S. El Moselhy Department of Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Egypt
Mohamed Nasr El-Sharawi Department of Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Egypt
Marwa Waheed Abd Elhady Department of Pediatrics and Pediatric Cardiology, Faculty of Medicine, Ain Shams University, Egypt
Mohamed Awad Ibrahim Qasim Department of Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Egypt https://orcid.org/0000-0002-9287-9926
Ragia Marei Said Department of Pediatrics and Pediatric Nephrology, Faculty of Medicine, Ain Shams University, Egypt https://orcid.org/0000-0002-0067-5222

DOI:

https://doi.org/10.6000/1929-4247.2024.13.03.7

Keywords:

Centers for disease control and prevention, hemodialysis, pediatric, vascular access infection

Abstract

Background: Vascular access-related infection (VARI) is a serious issue in pediatric end-stage kidney disease (ESKD) patients on regular hemodialysis.

Objective: To estimate the frequency of vascular access-related infections in hemodialysis (HD) children and to assess the effect of the implementation of CDC guidelines and tools on the prevention of VARI.

Subjects and Methods: This study was conducted on 110 patients with ESKD on regular hemodialysis at the Pediatric Dialysis Unit, Ain Shams University, from August 2019 to September 2021, retrospectively for one year and prospectively for another year after implementing the CDC infection control procedures.

Besides full history taking, vascular access history, and thorough clinical examination, lab investigations for VARI diagnosis and echocardiography were performed. CDC infection control procedures were implemented for one year, and VARI was re-evaluated.

Results: The total number of patients enrolled in the study was 110, they were 58 males (52.7%) and 52 females (47.3%). The incidence of infection per 1000 vascular access days in both years was highest in patients with NTVCs (10.447 /1000 NTVC days, 6.861 /1000 NTVCs days), followed by patients with TVCs (1.051/1000 TVC days, 0.604 /1000 TVC days) then patients with AVF, (0.141/1000 AVF days, 0.046 /1000 AVF days). The mortality from vascular access-related infections in the first year was higher than in the second year, with 5 patients (10.2%) and 1 patient (3.8%), respectively.

The average duration of hospital stays (PPY) due to VARI (total admission days 8.09 and ward admission days 6.41) in the first year were significantly higher than in the second year, 4.04, 3.20 days/PPY, respectively.

Conclusion: The incidence of vascular access infection (VAI) is higher with non-tunneled catheters and lowest with Arteriovenous fistulae (AVF). To reduce the risk of VARI and hospitalization, proper infection control procedures must be implemented.

References

Shi Y, Tong C, Zhang M, Gao X. Altered functional connectivity density in the brains of hemodialysis end-stage renal disease patients: An in vivo resting-state functional MRI study. PLoS One 2019; 14(12): e0227123. https://doi.org/10.1371/journal.pone.0227123

Al-Barshomy SM, El-Antony NG, Sakr M, El Sokary RH. Epidemiology of Central Venous Catheters Infection in Hemodialysis Patients. Egy J Med Microbiol 2021; 82(2): 225-30. https://doi.org/10.21608/ejhm.2021.142815

Patel PR and Brinsley-Rainisch K. The making dialysis safer for patients coalition: a new partnership to prevent hemodialysis-related infections. Clin J Am Soc Nephrol 2018; 13(1): 175-81. https://doi.org/10.2215/CJN.02730317

Lee T, Mokrzycki M, Moist L, Maya I, Vazquez M, Lok CE. North American Vascular Access Consortium. Standardized definitions for hemodialysis vascular access. Semin Dial 2011; (5): 515-24. https://doi.org/10.1111/j.1525-139X.2011.00969.x

National Kidney Foundation. KDOQI. clinical practice guidelines for Hemodialysis Adequacy. Am J Kidney Dis 2015; 66(5): 884-930. https://doi.org/10.1053/j.ajkd.2015.07.015

Centers for disease control and prevention.Dialysis safety: infection prevention tools 2017. https://www.cdc.gov/dialysis/index.html.

Sethi J, Bagai S, Ramachandran R, Kumar V, Rathi M, Kohli HS., et al.Time to revisit the use of nontunneled dialysis vascular catheters even in cost-limited setting. Indian J Nephrol 2018; 28(5): 406-7. https://doi.org/10.4103/ijn.IJN_443_17

Bhojaraja MV, Prabhu RA, Nagaraju SP, Ramachandra I.Hemodialysis catheter-related blood stream infections:a single-center experience. J Nephropharmacol 2023;12(2): e10475. https://doi.org/10.34172/npj.2022.10475

Hasanoglu I, Guner R, Sahin S, et al. Surveillance of hemodialysis related infections: a prospective multicenter study. Sci Rep 2022; 12(1): 22240. https://doi.org/10.1038/s41598-022-24820-3

Mohamed H, Ali A, Browne LD, O'Connell NH, Casserly L, Stack AG, et al. Determinants and outcomes of access-related bloodstream infections among Irish haemodialysis patients; a cohort study. BMC Nephrol 2019; 20(1): 68. https://doi.org/10.1186/s12882-019-1253-x

Sahli F, Feidjel R, Laalaoui R. Hemodialysis catheter-related infection: rates, risk factors, and pathogens. Journal of infection and public health 2016; 10(4): 403-8. https://doi.org/10.1016/j.jiph.2016.06.008

Krzanowski M, Janda K, Chowaniec E, Sułowicz W. Hemodialysis vascular access infection and mortality in maintenance hemodialysis patients. Przegl Lek 2011; 68(12): 1157-61.

Wang K, Wang P, Liang X, Lu X, Liu Z. Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China. BMJ Open 2015; 5(11): e007136. https://doi.org/10.1136/bmjopen-2014-007136

Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 2004; 19(3): 670-7. https://doi.org/10.1093/ndt/gfg581

Borzych-Duzalka D, Shroff R, Ariceta G, et al. Vascular access choice, complications, and outcomes in children on maintenance hemodialysis: findings from the International Pediatric Hemodialysis Network (IPHN) Registry. Am J Kidney Dis 2019; 74(2): 193-202. https://doi.org/10.1053/j.ajkd.2019.02.014

Albuquerque SE, Cavalcante Rde S, Ponce D, Fortaleza CM. Epidemiology of healthcare-associated infections among patients from a hemodialysis unit in southeastern Brazil. Braz J Infect Dis 2014; 18(3): 327-30. https://doi.org/10.1016/j.bjid.2013.10.001

Yahia A, Ali MM, Zedan MM, Moemen D. Hemodialysis catheter-related infections among pediatric patients in Mansoura University Children Hospital. Egyptian J Med Microbiol 2022; 31(1): 7-14. https://doi.org/10.21608/ejmm.2022.211924

Kumar G.Catheter-related blood stream infections among children on hemodialysis over 7 years: A single-center experience. Asian J Pediatr Nephrol 2021; 4(1): 22. https://doi.org/10.4103/ajpn.ajpn_31_20

Momeni A, Mardani S, Kabiri M, Amiri M. Comparison of complications of arteriovenous fistula with permanent catheter in hemodialysis patients: a six-month follow-up. Adv Biomed Res 2017; 28(6): 106. https://doi.org/10.4103/2277-9175.213666

Marsenic O, Rodean J, Richardson T, et al. Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative. Pediatr Nephrol 2020; 35(1): 135-43. https://doi.org/10.1007/s00467-019-04384-7

Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2019; 73(3 Suppl 1): A7-A8.

Baracco R, Mattoo T, Jain A, Kapur G, Valentini RP. (Reducing central venous catheters in chronic hemodialysis--a commitment to arteriovenous fistula creation in children. Pediatr Nephrol 2014; 29(10): 2013-20. https://doi.org/10.1007/s00467-013-2744-9

Chotikanatis K, Suman N, Bäcker M, Paudyal B, Schoeneman M, Kohlhoff S, et al. Pediatric Fistula Initiative: reducing bloodstream infections in an outpatient pediatric hemodialysis center. J Pediatric Infect Dis Soc 2015; 4(4): 363-6. https://doi.org/10.1093/jpids/piu053

Sarah HY, Kallen AJ, Hess S, BrenVR, Lincoln ME, Downham G, et al. Sustained infection reduction in outpatient hemodialysis centers participating in a collaborative bloodstream infection prevention effort. Infect Control Hosp Epidemiol 2016; 37(7): 863-6. https://doi.org/10.1017/ice.2016.22

Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19(1): 108-20. https://doi.org/10.1093/ndt/gfg483

Molnar AO, Moist L, Klarenbach S, et al. Hospitalizations in dialysis patients in Canada: anational cohort study. Can J Kidney Health Dis 2018; 5: 2054358118780372. https://doi.org/10.1177/2054358118780372

Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2017; 69(3)(suppl 1): S1-S688. https://doi.org/10.1053/j.ajkd.2017.03.001